Report Detail

Request for Sample of this report

Pharma & Healthcare Global Vaccine for Influenza Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4562570
    • |
  • 21 October, 2023
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Vaccine for Influenza market size was valued at USD 8056.5 million in 2022 and is forecast to a readjusted size of USD 11570 million by 2029 with a CAGR of 5.3% during review period.
Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
The Global Info Research report includes an overview of the development of the Vaccine for Influenza industry chain, the market status of 6 Months to 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), > 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Vaccine for Influenza.
Regionally, the report analyzes the Vaccine for Influenza markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Vaccine for Influenza market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Vaccine for Influenza market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Vaccine for Influenza industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Units), revenue generated, and market share of different by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Vaccine for Influenza market.
Regional Analysis: The report involves examining the Vaccine for Influenza market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Vaccine for Influenza market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Vaccine for Influenza:
Company Analysis: Report covers individual Vaccine for Influenza manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Vaccine for Influenza This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (6 Months to 3 Years, > 3 Years).
Technology Analysis: Report covers specific technologies relevant to Vaccine for Influenza. It assesses the current state, advancements, and potential future developments in Vaccine for Influenza areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Vaccine for Influenza market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Vaccine for Influenza market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market segment by Application
6 Months to 3 Years
> 3 Years
Major players covered
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccine for Influenza product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vaccine for Influenza, with price, sales, revenue and global market share of Vaccine for Influenza from 2018 to 2023.
Chapter 3, the Vaccine for Influenza competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine for Influenza breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Vaccine for Influenza market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vaccine for Influenza.
Chapter 14 and 15, to describe Vaccine for Influenza sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Vaccine for Influenza
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Vaccine for Influenza Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Trivalent Influenza Vaccine
    • 1.3.3 Quadrivalent Influenza Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Vaccine for Influenza Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 6 Months to 3 Years
    • 1.4.3 > 3 Years
  • 1.5 Global Vaccine for Influenza Market Size & Forecast
    • 1.5.1 Global Vaccine for Influenza Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Vaccine for Influenza Sales Quantity (2018-2029)
    • 1.5.3 Global Vaccine for Influenza Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Vaccine for Influenza Product and Services
    • 2.1.4 Sanofi Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Sanofi Recent Developments/Updates
  • 2.2 CSL
    • 2.2.1 CSL Details
    • 2.2.2 CSL Major Business
    • 2.2.3 CSL Vaccine for Influenza Product and Services
    • 2.2.4 CSL Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 CSL Recent Developments/Updates
  • 2.3 GSK
    • 2.3.1 GSK Details
    • 2.3.2 GSK Major Business
    • 2.3.3 GSK Vaccine for Influenza Product and Services
    • 2.3.4 GSK Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 GSK Recent Developments/Updates
  • 2.4 Viatris
    • 2.4.1 Viatris Details
    • 2.4.2 Viatris Major Business
    • 2.4.3 Viatris Vaccine for Influenza Product and Services
    • 2.4.4 Viatris Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Viatris Recent Developments/Updates
  • 2.5 AstraZeneca
    • 2.5.1 AstraZeneca Details
    • 2.5.2 AstraZeneca Major Business
    • 2.5.3 AstraZeneca Vaccine for Influenza Product and Services
    • 2.5.4 AstraZeneca Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 AstraZeneca Recent Developments/Updates
  • 2.6 Hualan Bio
    • 2.6.1 Hualan Bio Details
    • 2.6.2 Hualan Bio Major Business
    • 2.6.3 Hualan Bio Vaccine for Influenza Product and Services
    • 2.6.4 Hualan Bio Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Hualan Bio Recent Developments/Updates
  • 2.7 Changchun Institute of Biological
    • 2.7.1 Changchun Institute of Biological Details
    • 2.7.2 Changchun Institute of Biological Major Business
    • 2.7.3 Changchun Institute of Biological Vaccine for Influenza Product and Services
    • 2.7.4 Changchun Institute of Biological Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Changchun Institute of Biological Recent Developments/Updates
  • 2.8 Sinovac
    • 2.8.1 Sinovac Details
    • 2.8.2 Sinovac Major Business
    • 2.8.3 Sinovac Vaccine for Influenza Product and Services
    • 2.8.4 Sinovac Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Sinovac Recent Developments/Updates
  • 2.9 BCHT
    • 2.9.1 BCHT Details
    • 2.9.2 BCHT Major Business
    • 2.9.3 BCHT Vaccine for Influenza Product and Services
    • 2.9.4 BCHT Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 BCHT Recent Developments/Updates
  • 2.10 Jiangsu GDK
    • 2.10.1 Jiangsu GDK Details
    • 2.10.2 Jiangsu GDK Major Business
    • 2.10.3 Jiangsu GDK Vaccine for Influenza Product and Services
    • 2.10.4 Jiangsu GDK Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Jiangsu GDK Recent Developments/Updates
  • 2.11 KM Biologics
    • 2.11.1 KM Biologics Details
    • 2.11.2 KM Biologics Major Business
    • 2.11.3 KM Biologics Vaccine for Influenza Product and Services
    • 2.11.4 KM Biologics Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 KM Biologics Recent Developments/Updates

3 Competitive Environment: Vaccine for Influenza by Manufacturer

  • 3.1 Global Vaccine for Influenza Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Vaccine for Influenza Revenue by Manufacturer (2018-2023)
  • 3.3 Global Vaccine for Influenza Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Vaccine for Influenza by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Vaccine for Influenza Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Vaccine for Influenza Manufacturer Market Share in 2022
  • 3.5 Vaccine for Influenza Market: Overall Company Footprint Analysis
    • 3.5.1 Vaccine for Influenza Market: Region Footprint
    • 3.5.2 Vaccine for Influenza Market: Company Product Type Footprint
    • 3.5.3 Vaccine for Influenza Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Vaccine for Influenza Market Size by Region
    • 4.1.1 Global Vaccine for Influenza Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Vaccine for Influenza Consumption Value by Region (2018-2029)
    • 4.1.3 Global Vaccine for Influenza Average Price by Region (2018-2029)
  • 4.2 North America Vaccine for Influenza Consumption Value (2018-2029)
  • 4.3 Europe Vaccine for Influenza Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Vaccine for Influenza Consumption Value (2018-2029)
  • 4.5 South America Vaccine for Influenza Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Vaccine for Influenza Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Vaccine for Influenza Sales Quantity by Type (2018-2029)
  • 5.2 Global Vaccine for Influenza Consumption Value by Type (2018-2029)
  • 5.3 Global Vaccine for Influenza Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Vaccine for Influenza Sales Quantity by Application (2018-2029)
  • 6.2 Global Vaccine for Influenza Consumption Value by Application (2018-2029)
  • 6.3 Global Vaccine for Influenza Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Vaccine for Influenza Sales Quantity by Type (2018-2029)
  • 7.2 North America Vaccine for Influenza Sales Quantity by Application (2018-2029)
  • 7.3 North America Vaccine for Influenza Market Size by Country
    • 7.3.1 North America Vaccine for Influenza Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Vaccine for Influenza Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Vaccine for Influenza Sales Quantity by Type (2018-2029)
  • 8.2 Europe Vaccine for Influenza Sales Quantity by Application (2018-2029)
  • 8.3 Europe Vaccine for Influenza Market Size by Country
    • 8.3.1 Europe Vaccine for Influenza Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Vaccine for Influenza Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Vaccine for Influenza Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Vaccine for Influenza Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Vaccine for Influenza Market Size by Region
    • 9.3.1 Asia-Pacific Vaccine for Influenza Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Vaccine for Influenza Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Vaccine for Influenza Sales Quantity by Type (2018-2029)
  • 10.2 South America Vaccine for Influenza Sales Quantity by Application (2018-2029)
  • 10.3 South America Vaccine for Influenza Market Size by Country
    • 10.3.1 South America Vaccine for Influenza Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Vaccine for Influenza Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Vaccine for Influenza Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Vaccine for Influenza Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Vaccine for Influenza Market Size by Country
    • 11.3.1 Middle East & Africa Vaccine for Influenza Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Vaccine for Influenza Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Vaccine for Influenza Market Drivers
  • 12.2 Vaccine for Influenza Market Restraints
  • 12.3 Vaccine for Influenza Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Vaccine for Influenza and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Vaccine for Influenza
  • 13.3 Vaccine for Influenza Production Process
  • 13.4 Vaccine for Influenza Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Vaccine for Influenza Typical Distributors
  • 14.3 Vaccine for Influenza Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Vaccine for Influenza. Industry analysis & Market Report on Vaccine for Influenza is a syndicated market report, published as Global Vaccine for Influenza Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Vaccine for Influenza market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo